# Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic TH1 cell responses in Crohn’s disease

**Authors:** Gabriela Rios Martini, Ekaterina Tikhonova, Elisa Rosati, Meghan Bialt DeCelie, Laura Katharina Sievers, Florian Tran, Matthias Lessing, Arne Bergfeld, Sophia Hinz, Susanna Nikolaus, Julia Kümpers, Anna Matysiak, Philipp Hofmann, Carina Saggau, Stephan Schneiders, Ann-Kristin Kamps, Gunnar Jacobs, Wolfgang Lieb, Jochen Maul, Britta Siegmund, Barbara Seegers, Holger Hinrichsen, Hans-Heinrich Oberg, Daniela Wesch, Stefan Bereswill, Markus M. Heimesaat, Jan Rupp, Olaf Kniemeyer, Axel A. Brakhage, Sascha Brunke, Bernhard Hube, Konrad Aden, Andre Franke, Iliyan D. Iliev, Alexander Scheffold, Stefan Schreiber, Petra Bacher

PMC · DOI: 10.1038/s41591-023-02556-5 · Nature Medicine · 2023-09-25

## TL;DR

Crohn’s disease involves abnormal T cell responses to gut and dietary yeasts, leading to inflammation.

## Contribution

Identifies cross-reactive T cells activated by commensal and food yeasts as drivers of CD4+ TH1 responses in Crohn’s disease.

## Key findings

- Yeast-responsive CD4+ T cells in Crohn’s disease show a cytotoxic TH1 cell phenotype.
- T cell clones are selectively expanded and cross-reactive to multiple fungal species.
- Gut-resident and dietary yeasts contribute to chronic T cell activation in Crohn’s disease.

## Abstract

Aberrant CD4+ T cell reactivity against intestinal microorganisms is considered to drive mucosal inflammation in inflammatory bowel diseases. The disease-relevant microbial species and the corresponding microorganism-specific, pathogenic T cell phenotypes remain largely unknown. In the present study, we identified common gut commensal and food-derived yeasts, as direct activators of altered CD4+ T cell reactions in patients with Crohn’s disease (CD). Yeast-responsive CD4+ T cells in CD display a cytotoxic T helper cell (TH1 cell) phenotype and show selective expansion of T cell clones that are highly cross-reactive to several commensal, as well as food-derived, fungal species. This indicates cross-reactive T cell selection by repeated encounter with conserved fungal antigens in the context of chronic intestinal disease. Our results highlighted a role of yeasts as drivers of aberrant CD4+ T cell reactivity in patients with CD and suggest that both gut-resident fungal commensals and daily dietary intake of yeasts might contribute to chronic activation of inflammatory CD4+ T cell responses in patients with CD.

In patients with Crohn’s disease, CD4+ T cells with cytotoxic TH1 cell-like effector functions reactive against dietary and commensal yeasts are increased in blood and inflamed tissue compared with patients with ulcerative colitis and healthy controls.

## Linked entities

- **Diseases:** Crohn’s disease (MONDO:0005011), ulcerative colitis (MONDO:0005101)

## Full-text entities

- **Genes:** Tcrb (T cell receptor beta chain) [NCBI Gene 21577] {aka TCRbeta, Tib}, PRF1 (perforin 1) [NCBI Gene 5551] {aka HPLH2, P1, PFP}, Ms4a1 (membrane-spanning 4-domains, subfamily A, member 1) [NCBI Gene 12482] {aka Cd20, Ly-44, Ms4a2}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, IL21 (interleukin 21) [NCBI Gene 59067] {aka CVID11, IL-21, Za11}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, CD14 (CD14 molecule) [NCBI Gene 929], HOPX (HOP homeobox) [NCBI Gene 84525] {aka CAMEO, HOD, HOP, LAGY, NECC1, OB1}, CD40 (CD40 molecule) [NCBI Gene 958] {aka Bp50, CDW40, TNFRSF5, p50}, KRT20 (keratin 20) [NCBI Gene 54474] {aka CD20, CK-20, CK20, K20, KRT21}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, SLAMF7 (SLAM family member 7) [NCBI Gene 57823] {aka 19A, CD319, CRACC, CS1}, NELFCD (negative elongation factor complex member C/D) [NCBI Gene 51497] {aka HSPC130, NELF-C, NELF-D, TH1, TH1L}, CSF2 (colony stimulating factor 2) [NCBI Gene 1437] {aka CSF, GMCSF}, CCR7 (C-C motif chemokine receptor 7) [NCBI Gene 1236] {aka BLR2, CC-CKR-7, CCR-7, CD197, CDw197, CMKBR7}, Il17a (interleukin 17A) [NCBI Gene 16171] {aka Ctla-8, Ctla8, IL-17, IL-17A, Il17}, PFY1 (profilin) [NCBI Gene 854289] {aka CLS5, PRF1}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, Cnbd2 (cyclic nucleotide binding domain containing 2) [NCBI Gene 70873] {aka 4921517L17Rik, 5430421B09Rik, Cris}, Cd4 (CD4 antigen) [NCBI Gene 12504] {aka L3T4, Ly-4}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, Trav6-3 (T cell receptor alpha variable 6-3) [NCBI Gene 328483] {aka Gm13948, Gm193, Gm4, TCR}, IL2 (interleukin 2) [NCBI Gene 3558] {aka IL-2, TCGF, lymphokine}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, TRAC (T cell receptor alpha constant) [NCBI Gene 28755] {aka IMD7, TCRA, TRCA}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, Cd14 (CD14 antigen) [NCBI Gene 12475], Nelfcd (negative elongation factor complex member C/D, Th1l) [NCBI Gene 57314] {aka 2410003I03Rik, NELF-D, Th1, Th1l}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, CD40LG (CD40 ligand) [NCBI Gene 959] {aka CD154, CD40L, HIGM1, IGM, IMD3, T-BAM}, TRBC1 (T cell receptor beta constant 1) [NCBI Gene 28639] {aka BV05S1J2.2, TCRB, TCRBC1}, Cd40lg (CD40 ligand) [NCBI Gene 21947] {aka CD154, CD40-L, Cd40l, HIGM1, IGM, IMD3}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, Cd40 (CD40 antigen) [NCBI Gene 21939] {aka Bp50, GP39, HIGM1, IGM, IMD3, T-BAM}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}
- **Diseases:** fungal (MESH:D009181), IBD (MESH:D015212), HD (MESH:D006816), UC (MESH:D003093), IECs (MESH:C567703), Inflammation (MESH:D007249), intestinal disease (MESH:D007410), ASCA+ CD (MESH:D003424), ASCAs (MESH:D016736), chronic diseases (MESH:D002908), inflammatory cytokines (MESH:D000080424), Cytotoxicity (MESH:D064420), cancer (MESH:D009369), viral infections (MESH:D014777), CMV (MESH:D003586)
- **Chemicals:** penicillin (MESH:D010406), agar (MESH:D000362), amino acids (MESH:D000596), threonine (MESH:D013912), glycerol (MESH:D005990), carbon (MESH:D002244), mannans (MESH:D008351), poly(A) (MESH:D011061), IFX (MESH:D007069), NaOH (MESH:D012972), Tween-80 (MESH:D011136), phenylalanine (MESH:D010649), streptomycin (MESH:D013307), HCl (MESH:D006851), 5-ASA (MESH:D019804), adenine (MESH:D000225), CO2 (MESH:D002245), uracil (MESH:D014498), lysine (MESH:D008239), Brefeldin A (MESH:D020126), biotin (MESH:D001710), Adalimumab (MESH:D000068879), dextrose (MESH:D005947), tyrosine (MESH:D014443), Triton X-100 (MESH:D017830), tryptophan (MESH:D014364), Vedolizumab (MESH:C543529), leucine (MESH:D007930), EDTA (MESH:D004492), glutamine (MESH:D005973), ASCA (-), arginine (MESH:D001120), glycerol monostearate (MESH:C048159), Ustekinumab (MESH:D000069549), nitrogen (MESH:D009584), Ionomycin (MESH:D015759), 2-mercaptoethanol (MESH:D008623), Infliximab (MESH:D000069285), olive oil (MESH:D000069463), methionine (MESH:D008715), water (MESH:D014867), amphotericin B (MESH:D000666)
- **Species:** Candida albicans (species) [taxon 5476], Faecalibacterium prausnitzii (species) [taxon 853], [Clostridium] leptum (species) [taxon 1535], Kluyveromyces lactis (species) [taxon 28985], Escherichia coli (E. coli, species) [taxon 562], Candida dubliniensis (species) [taxon 42374], Nakaseomyces glabratus (species) [taxon 5478], Penicillium roqueforti (species) [taxon 5082], Debaryomyces hansenii (species) [taxon 4959], Penicillium camemberti (species) [taxon 5075], Lodderomyces parapsilosis (species) [taxon 5480], Lodderomyces orthopsilosis (species) [taxon 273371], Akkermansia muciniphila (species) [taxon 239935], Mus musculus (house mouse, species) [taxon 10090], human gammaherpesvirus 4 (Epstein Barr virus, no rank) [taxon 10376], Lactococcus lactis (species) [taxon 1358], Klebsiella pneumoniae (species) [taxon 573], Williopsis jadinii (species) [taxon 4903], Segatella copri (species) [taxon 165179], Human alphaherpesvirus 3 (Varicella-zoster virus, no rank) [taxon 10335], Lacticaseibacillus rhamnosus (species) [taxon 47715], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Severe acute respiratory syndrome coronavirus 2 (no rank) [taxon 2697049], Homo sapiens (human, species) [taxon 9606], Adenoviridae (family) [taxon 10508], Human betaherpesvirus 6 (species) [taxon 10368], Malassezia restricta (species) [taxon 76775], Saccharomyces pastorianus (lager yeast, species) [taxon 27292], Geotrichum candidum (species) [taxon 1173061], Bacteroides fragilis (species) [taxon 817], Human alphaherpesvirus 1 (Herpes simplex virus type 1, no rank) [taxon 10298], Candida tropicalis (species) [taxon 5482], S. boulardii [taxon 252598]
- **Mutations:** C for 7-10, T2A
- **Cell lines:** IECs — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_6C15)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC10579100/full.md

## Figures

16 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10579100/full.md

## References

62 references — full list in the complete paper: https://tomesphere.com/paper/PMC10579100/full.md

---
Source: https://tomesphere.com/paper/PMC10579100